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The Joint Research Centre (JRC) is a Directorate-General
(DG) of the European Commission (EC), it was established
in 1957 and its mission is to provide independent,
evidence-based scientific and technical support through-
out the EU policy cycle. Health is a key European policy
area and research on Rare Diseases (RD) is identified as a
priority in both the Commission Communication on RD:
Europe’s challenges COMM (2008) 679 final and the
Council Recommendation on an action in the field of RD
(2009/C 151/02).
The specificities of RD – limited number of patients and
scarcity of information – single them out as a unique
domain for which an action at European level has high
potential added value. For this reason and in the context
of developing a long-term EU strategy in the area of health
information including RD data collection, DG Health and
Consumers (SANCO) and the JRC started an initiative
aimed to improve the sustainability of the results achieved
over the past years. Taking into account that the current
fragmentation of data sources is a key obstacle to steering
EU policy and to performing high quality research (e.g.
conducting epidemiological, clinical, pharmacological
studies) and in the end to advancing knowledge on RD,
the two DGs agreed on the development of the European
Platform for RD registries. The main purpose of the
Platform which will be established at the JRC is to support
the existing registries by promoting their interoperability
and accessibility, by improving RD data comparability and
reliability. It will also support the development of new
registries. This ‘hub’ will facilitate data analysis within and
across many RD and across Europe and provide sound
information on RD for policy, clinical trials and research.
The Platform is intended to provide a central access
point for information on RD patients registries for all
stakeholders – health professionals, researchers, patients,
public health authorities, industry, etc. Thus the benefits
of collaboration and maximisation of limited resources are
most obvious in a concerted action with the final aim of
improving the quality of care and the quality of life for RD
patients.
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